Advertisement
Screener

Eledon Pharmaceuticals, Inc. (ELDN) Graph

ELDN Revenue Flow

A current filed revenue breakdown could not be established from the retained filing evidence.

  • 2026-06-30: Research and development $18.23M; Operating expenses $22.87M; Income tax (m); Net income -$31.63M.
  • 2026-03-31: Research and development $17.20M; Operating expenses $21.18M; Income tax (m); Net income -$39.02M.
  • 2025-12-31: Research and development $17.49M*; Operating expenses $21.48M*; Income tax (m); Net income -$10.45M*.
  • 2025-09-30: Research and development $14.97M; Operating expenses $19.07M; Income tax (m); Net income -$17.46M.

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endResearch and developmentOperating expensesIncome taxNet income
2026-06-30$18.23M$22.87M(m)-$31.63M
2026-03-31$17.20M$21.18M(m)-$39.02M
2025-12-31$17.49M*$21.48M*(m)-$10.45M*
2025-09-30$14.97M$19.07M(m)-$17.46M
2025-06-30$20.28M$24.73M(m)-$11.22M
2025-03-31$13.53M$17.96M(m)-$6.50M
2024-09-30$16.52M$20.51M(m)$76.97M
2024-06-30$10.11M$14.50M(m)-$44.91M
2024-03-31$7.41M$10.87M(m)-$23.63M
2023-09-30$7.93M$11.20M(m)-$9.91M
2023-06-30$7.20M$10.35M(m)-$65.76M
2023-03-31$8.11M$11.11M(m)-$10.77M
2022-09-30$7.45M$10.60M(m)-$10.47M
2022-06-30$5.74M$9.28M(m)-$9.25M
2022-03-31$6.63M$9.86M(m)-$9.86M
2021-09-30$7.66M$10.51M-$686.00K-$9.82M
2021-06-30$4.24M$7.97M-$588.00K-$7.38M
2021-03-31$5.65M$9.01M-$501.00K-$8.50M
2020-09-30$615.00K$6.15M(m)-$6.14M
2020-06-30$832.00K$2.59M(m)-$2.59M
2020-03-31$1.65M$3.38M(m)-$8.18M
2019-09-30$1.51M$2.92M(m)-$2.89M
2019-06-30$2.30M$4.09M(m)-$4.09M
2019-03-31$2.99M$4.88M(m)-$4.88M
2018-09-30$1.65M$3.50M(m)-$3.50M
2018-06-30$1.33M$3.19M(m)-$3.19M
2018-03-31$1.10M$2.79M(m)-$2.81M
2017-09-30$517.00K$2.96M(m)-$2.97M
2017-06-30$533.00K$6.67M(m)-$6.66M
2017-03-31$479.00K$1.39M$0.00-$1.37M
2016-12-31(m)(m)$0.00*-$3.74M
2016-09-30$1.05M$1.62M(m)-$2.04M
2016-06-30$592.00K$932.00K(m)-$1.00M
2016-03-31$7.93M$11.48M$0.00-$11.43M
2015-12-31(m)(m)(m)-$11.02M
2015-09-30$8.49M$11.91M(m)-$11.85M
2015-06-30$5.86M$8.98M(m)-$8.96M
2015-03-31$10.56M$13.30M$0.00-$13.26M
2014-12-31(m)(m)(m)-$6.21M
2014-09-30$2.83M$6.42M(m)-$6.39M
2014-06-30$4.39M$5.88M(m)-$5.85M
2014-03-31$3.56M$4.89M$0.00-$4.85M
2013-12-31(m)(m)(m)-$5.53M
2013-09-30$2.70M$3.37M(m)-$3.37M
2013-06-30(m)(m)(m)-$4.45M
2013-03-31(m)(m)(m)-$2.39M

Revenue and expense 6 month

Period endResearch and developmentOperating expensesIncome taxNet income
2026-06-30$35.43M$44.05M(m)-$70.66M
2025-06-30$33.81M$42.70M(m)-$17.71M
2024-06-30$17.52M$25.37M(m)-$68.54M
2023-06-30$15.31M$21.46M(m)-$76.53M
2022-06-30$12.38M$19.14M(m)-$19.11M
2021-06-30$9.89M$16.98M-$1.09M-$15.88M
2020-06-30$2.48M$5.97M(m)-$10.76M
2019-06-30$5.29M$8.96M(m)-$8.97M
2018-06-30$2.43M$5.98M(m)-$6.00M
2017-06-30$1.01M$8.05M(m)-$8.04M
2016-06-30$1.28M$2.04M$0.00-$2.10M
2015-06-30$16.41M$22.28M$0.00-$22.22M
2014-06-30$7.95M$10.78M$0.00-$10.70M

Revenue and expense 9 month

Period endResearch and developmentOperating expensesIncome taxNet income
2025-09-30$48.78M$61.77M(m)-$35.17M
2024-09-30$34.04M$45.88M(m)$8.43M
2023-09-30$23.25M$32.66M(m)-$86.44M
2022-09-30$19.83M$29.74M(m)-$29.58M
2021-09-30$17.55M$27.48M-$1.77M-$25.70M
2020-09-30$3.10M$12.12M(m)-$16.91M
2019-09-30$6.79M$11.88M(m)-$11.87M
2018-09-30$4.08M$9.48M(m)-$9.49M
2017-09-30$1.53M$11.02M(m)-$11.01M
2016-09-30$2.33M$3.66M$0.00-$4.14M
2015-09-30$24.91M$34.19M$0.00-$34.07M
2014-09-30$10.77M$17.20M$0.00-$17.09M
2013-09-30$7.85M$10.20M(m)-$10.20M

Revenue and expense 12 month

Period endRevenueResearch and developmentOperating expensesIncome taxNet income
2025-12-31(m)$66.27M$83.25M$35.00K-$45.62M
2024-12-31(m)$51.96M$70.58M$431.00K-$36.18M
2023-12-31(m)$30.31M$43.00M$0.00-$116.54M
2022-12-31(m)$27.08M$88.43M$0.00-$87.97M
2021-12-31(m)$23.73M$36.87M-$2.35M-$34.51M
2020-12-31(m)$6.13M$18.46M-$404.00K-$22.81M
2019-12-31(m)$8.13M$16.05M(m)-$16.01M
2018-12-31(m)$6.82M$14.06M(m)-$14.06M
2017-12-31(m)$2.02M$13.12M(m)-$13.12M
2016-12-31$0.00$3.19M$5.13M$0.00-$5.66M
2015-12-31$0.00$32.64M$45.26M$0.00-$45.09M
2014-12-31(m)$14.58M$23.46M$0.00-$23.30M
2013-12-31(m)$12.20M$15.75M$0.00-$15.72M
2012-12-31(m)$7.37M$9.65M(m)-$9.65M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Whitehawk Therapeutics, Inc. (WHWK)United States$0.221B
Foghorn Therapeutics Inc. (FHTX)United States$0.213B-4.43
NATURES SUNSHINE PRODUCTS INC (NATR)United States$0.228B20.51
Keros Therapeutics, Inc. (KROS)United States$0.229B-2.55
Cartesian Therapeutics, Inc. (RNAC)United States$0.231B-2.04
Nkarta, Inc. (NKTX)United States$0.205B-1.73
SIGA TECHNOLOGIES INC (SIGA)United States$0.234B-93.33
Sionna Therapeutics, Inc. (SION)United States$0.236B-20.37
ORAMED PHARMACEUTICALS INC. (ORMP)$0.199B1.13
Camp4 Therapeutics Corp (CAMP)United States$0.240B-2.12